Kimberly E. Vanover

3.4k total citations
67 papers, 2.0k citations indexed

About

Kimberly E. Vanover is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, Kimberly E. Vanover has authored 67 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 25 papers in Psychiatry and Mental health and 20 papers in Biological Psychiatry. Recurrent topics in Kimberly E. Vanover's work include Tryptophan and brain disorders (20 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Neuroscience and Neuropharmacology Research (17 papers). Kimberly E. Vanover is often cited by papers focused on Tryptophan and brain disorders (20 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Neuroscience and Neuropharmacology Research (17 papers). Kimberly E. Vanover collaborates with scholars based in United States, Germany and Sweden. Kimberly E. Vanover's co-authors include Robert E. Davis, Gretchen L. Snyder, James E. Barrett, Sharon Mates, Paul Greengard, Jennifer Warner‐Schmidt, John Marshall, Emily Y. Chen, David M. Weiner and William L. Woolverton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Kimberly E. Vanover

64 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly E. Vanover United States 26 731 705 619 521 364 67 2.0k
Dorotea Mück‐Šeler Croatia 31 723 1.0× 744 1.1× 446 0.7× 613 1.2× 425 1.2× 106 2.6k
Stevin H. Zorn United States 20 954 1.3× 662 0.9× 795 1.3× 325 0.6× 225 0.6× 37 2.2k
István Gyertyán Hungary 26 1.2k 1.7× 758 1.1× 762 1.2× 176 0.3× 326 0.9× 83 2.2k
Anders Ettrup Denmark 22 780 1.1× 472 0.7× 340 0.5× 176 0.3× 267 0.7× 79 1.9k
Matea Nikolac Perković Croatia 28 523 0.7× 320 0.5× 677 1.1× 408 0.8× 213 0.6× 104 2.2k
Jana Tchekalarova Bulgaria 24 681 0.9× 325 0.5× 449 0.7× 188 0.4× 214 0.6× 115 1.7k
Sharon C. Cheetham United Kingdom 29 1.5k 2.0× 384 0.5× 845 1.4× 278 0.5× 558 1.5× 70 2.8k
Doug Hussey Canada 19 1.4k 1.9× 522 0.7× 541 0.9× 387 0.7× 764 2.1× 21 2.7k
Ede Frecska Hungary 20 539 0.7× 561 0.8× 361 0.6× 290 0.6× 228 0.6× 80 1.8k
Maciej Gąsior United States 35 1.7k 2.3× 893 1.3× 1.2k 1.9× 164 0.3× 242 0.7× 100 3.3k

Countries citing papers authored by Kimberly E. Vanover

Since Specialization
Citations

This map shows the geographic impact of Kimberly E. Vanover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly E. Vanover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly E. Vanover more than expected).

Fields of papers citing papers by Kimberly E. Vanover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly E. Vanover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly E. Vanover. The network helps show where Kimberly E. Vanover may publish in the future.

Co-authorship network of co-authors of Kimberly E. Vanover

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly E. Vanover. A scholar is included among the top collaborators of Kimberly E. Vanover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly E. Vanover. Kimberly E. Vanover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vadodaria, Krishna C., Jordi Serrats, William D. Brubaker, et al.. (2025). ENX-104: a selective and potent D2/D3 receptor antagonist enhances dopamine neurotransmission and reward responsiveness in translational rodent models. Neuropsychopharmacology.
2.
Correll, Christoph U., Suresh Durgam, Hassan Lakkis, et al.. (2025). Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial. International Clinical Psychopharmacology. 41(2). 120–129. 1 indexed citations
3.
Snyder, Gretchen L., Peng Li, Lei Zhang, et al.. (2024). Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders. Psychopharmacology. 241(7). 1477–1490. 1 indexed citations
4.
Suppes, Trisha, Suresh Durgam, Richard Chen, et al.. (2023). Adjunctive lumateperone (ITI‐007) in the treatment of bipolar depression: Results from a randomized placebo‐controlled clinical trial. Bipolar Disorders. 25(6). 478–488. 16 indexed citations
5.
Calabrese, Joseph R., Suresh Durgam, Andrew Satlin, et al.. (2021). Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial. American Journal of Psychiatry. 178(12). 1098–1106. 65 indexed citations
6.
Correll, Christoph U., Kimberly E. Vanover, Robert E. Davis, et al.. (2021). Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia. Schizophrenia Research. 228. 198–205. 23 indexed citations
7.
Vanover, Kimberly E., Robert E. Davis, Yun Zhou, et al.. (2018). Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia. Neuropsychopharmacology. 44(3). 598–605. 58 indexed citations
8.
Snyder, Gretchen L., Jos Prickaerts, Lei Zhang, et al.. (2016). Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats. Psychopharmacology. 233(17). 3113–3124. 49 indexed citations
9.
Snyder, Gretchen L., et al.. (2016). Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future. Current Topics in Medicinal Chemistry. 16(29). 3385–3403. 198 indexed citations
10.
Snyder, Gretchen L., Kimberly E. Vanover, Hongwen Zhu, et al.. (2014). Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission. Psychopharmacology. 232(3). 605–621. 96 indexed citations
11.
Snyder, Gretchen L. & Kimberly E. Vanover. (2014). Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment. Current Pharmaceutical Design. 20(31). 5093–5103. 9 indexed citations
12.
Warner‐Schmidt, Jennifer, Kimberly E. Vanover, Emily Y. Chen, John Marshall, & Paul Greengard. (2011). Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proceedings of the National Academy of Sciences. 108(22). 9262–9267. 236 indexed citations
13.
Vanover, Kimberly E., Isaac Veinbergs, & Robert E. Davis. (2008). Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M₁ receptor agonist, AC-260584.. Behavioral Neuroscience. 122(3). 570–575. 28 indexed citations
14.
Vanover, Kimberly E., et al.. (2007). Pharmacokinetics, Tolerability, and Safety of ACP‐103 Following Single or Multiple Oral Dose Administration in Healthy Volunteers. The Journal of Clinical Pharmacology. 47(6). 704–714. 30 indexed citations
15.
Vanover, Kimberly E., Scott C. Harvey, Thomas Son, et al.. (2004). Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist. Journal of Pharmacology and Experimental Therapeutics. 310(3). 943–951. 18 indexed citations
16.
Vanover, Kimberly E.. (1999). Interaction of ethanol with excitatory amino acid receptor antagonists in mice. European Journal of Pharmacology. 368(2-3). 137–142. 12 indexed citations
17.
Vanover, Kimberly E., et al.. (1999). Pharmacological evaluation of a modified conflict procedure: punished drinking in non-water-deprived rats. Psychopharmacology. 145(3). 333–341. 22 indexed citations
18.
Vanover, Kimberly E.. (1997). Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion. European Journal of Pharmacology. 332(2). 115–119. 12 indexed citations
19.
Massey, Bill W., Kimberly E. Vanover, & William L. Woolverton. (1994). Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys. Drug and Alcohol Dependence. 34(2). 105–111. 6 indexed citations
20.
Vanover, Kimberly E., Michael A. Nader, & William L. Woolverton. (1992). Evaluation of the discriminative stimulus and reinforcing effects of sertraline in rhesus monkeys. Pharmacology Biochemistry and Behavior. 41(4). 789–793. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorotea Mück‐Šeler Breakdown of academic impact, for papers by Stevin H. Zorn Breakdown of academic impact, for papers by István Gyertyán Breakdown of academic impact, for papers by Anders Ettrup Breakdown of academic impact, for papers by Matea Nikolac Perković Breakdown of academic impact, for papers by Jana Tchekalarova Breakdown of academic impact, for papers by Sharon C. Cheetham Breakdown of academic impact, for papers by Doug Hussey Breakdown of academic impact, for papers by Ede Frecska Breakdown of academic impact, for papers by Maciej Gąsior
Rankless by CCL
2026